Healthy Dialogue最新文献

筛选
英文 中文
Catastrophic Drug Coverage in Canada 加拿大灾难性药物覆盖
Healthy Dialogue Pub Date : 2013-08-29 DOI: 10.25071/1929-8404.37158
Karlo Franko Azores
{"title":"Catastrophic Drug Coverage in Canada","authors":"Karlo Franko Azores","doi":"10.25071/1929-8404.37158","DOIUrl":"https://doi.org/10.25071/1929-8404.37158","url":null,"abstract":"There is currently no nationwide catastrophic drug coverage in Canada, and this creates many inequities with regards to the costs and accessibility of out-of-hospital (outpatient) prescription drugs. This paper examines why catastrophic drug coverage needs to be addressed as well as implemented in order to improve the inequities in provincial drug plans and the continued non-coverage of outpatient prescription drugs. This paper used the recommendation of the 2002 Romanow Commission as a point of reference for the need to implement catastrophic drug coverage in Canada. Moreover, the 2003 First Ministers’ Accord and 2004 First Ministers’ Meeting are used to reveal the government’s initiative to develop a Canadian catastrophic drug coverage policy that remains unaddressed and unimplemented to this day.","PeriodicalId":292608,"journal":{"name":"Healthy Dialogue","volume":"40 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2013-08-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"121723191","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 9
Trade Agreements and Pharmaceutical Patent Protection: Implications for the Governance over Pharmaceutical Products in Canada 贸易协定与药品专利保护:对加拿大药品治理的启示
Healthy Dialogue Pub Date : 2012-09-04 DOI: 10.25071/1929-8404.34702
D. Byng
{"title":"Trade Agreements and Pharmaceutical Patent Protection: Implications for the Governance over Pharmaceutical Products in Canada","authors":"D. Byng","doi":"10.25071/1929-8404.34702","DOIUrl":"https://doi.org/10.25071/1929-8404.34702","url":null,"abstract":"This paper was prepared for a course on Canadian health policy. Its purpose is to expose the harmful ramifications of international trade agreements on the pharmaceutical market in Canada and the governance surrounding this market. This paper will explore the various implications that trade agreements have on the affordability of drugs, the strength of intellectual property protection, and the transfer of authority and influence from government to “Big Pharma.” This paper will unravel the reality that trade agreements are not beneficial to the Canadian people looking to access an affordable pharmaceutical market, but rather, act quite contrary to this. Facts will show that trade agreements work to put money into the pockets of large brand-name pharmaceutical companies in the forms of billions of dollars of revenue and profit. This paper will encourage readers to question the feasibility of extending patent legislation for brand-name pharmaceutical products, the increasing role of trade agreements and the pharmaceutical industry in Canada, and the substitutability of brand-name drugs over cheaper generic alternatives.","PeriodicalId":292608,"journal":{"name":"Healthy Dialogue","volume":"16 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2012-09-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"127708069","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Harm Reduction Policy, Political Economy, and Insite 减少伤害政策、政治经济与社会
Healthy Dialogue Pub Date : 2012-09-04 DOI: 10.25071/1929-8404.34703
Guytano Virdo
{"title":"Harm Reduction Policy, Political Economy, and Insite","authors":"Guytano Virdo","doi":"10.25071/1929-8404.34703","DOIUrl":"https://doi.org/10.25071/1929-8404.34703","url":null,"abstract":"Abstract: This paper seeks to answer why Insite, Vancouver's safe injection facility, continues to be a controversial issue, given that empirical investigations of the facility have demonstrated that the site improves health and saves health care dollars. As Insite represented a shift to harm reduction policy, from historically dominant drug control policy, it has drawn opposition from local, national and international players.  Using a political economy framework, this paper looks at the population around Insite, examining who the clients are and whether the facility is beneficial to them.  The Downtown Eastside of Vancouver, where Insite is located, is known to be one of the poorest neighbourhoods in Canada, and as such the population is extremely marginalized (The Globe and Mail, 2008).  This paper argues that the attempts by the federal Conservative Party to shut down Insite are based on ideology rather than the effectiveness of the facility.  Using the Gramscian concept of hegemony, this paper argues that the federal Conservative Party attempted to use its hegemonic dominance to close down Insite.  This paper will also briefly discuss the legal history of Insite,  and the empirical literature, briefly summarizing the evidence researchers have found.","PeriodicalId":292608,"journal":{"name":"Healthy Dialogue","volume":"1 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2012-09-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"130191755","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书